Filetype
Allergic immunity is orchestrated by group 2 innate lymphoid cells (ILC2s) and type 2 helper T (Th2) cells prominently arrayed at epithelial- and microbial-rich barriers. However, ILC2s and Th2 cells are also present in fibroblast-rich niches within the adventitial layer of larger vessels and similar boundary structures in sterile deep tissues, and it remains unclear whether they undergo dynamic r
We report broadband UBV and/or BVRCIC CCD photometry for a total of 1857 stars in the thick-disk and halo populations of the Galaxy. The majority of our targets were selected as candidate field horizontal-branch or other A-type stars (FHB/ A, N = 576), or candidate low-metallicity stars (N = 1221), from the HK and Hamburg/ESO objective-prism surveys. Similar data for a small number of additional s
Acute myeloid leukemia with t(6; 9)(p22; q34) is listed as a distinct entity in the 2008 World Health Organization classification, but little is known about the clinical implications of t(6; 9)-positive myeloid leukemia in children. This international multicenter study presents the clinical and genetic characteristics of 62 pediatric patients with t(6; 9)/DEKNUP214-rearranged myeloid leukemia; 54
Swelling of the brain or spinal cord (CNS edema) affects millions of people every year. All potential pharmacological interventions have failed in clinical trials, meaning that symptom management is the only treatment option. The water channel protein aquaporin-4 (AQP4) is expressed in astrocytes and mediates water flux across the blood-brain and blood-spinal cord barriers. Here we show that AQP4
ABHD12 mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease. Although ABHD12 is suspected to play a role in the lysophosphatidylserine and/or endocannabinoid pathways, its precise functional role(s) leading to PHARC disease had not previously been characterized
PURPOSE: Despite impressive response rates following adoptive transfer of autologous tumor-infiltrating lymphocytes (TILs) in patients with metastatic melanoma, improvement is needed to increase the efficacy and broaden the applicability of this treatment. We evaluated the use of vemurafenib, a small-molecule BRAF inhibitor with immunomodulatory properties, as priming before TIL harvest and adopti
Purpose: To compare rates of tau biomarker positivity (T-status) per the 2018 Alzheimer’s Disease (AD) Research Framework derived from [18F]flortaucipir (FTP) PET visual assessment, FTP quantification, and cerebrospinal fluid (CSF) phosphorylated Tau-181 (PTau181). Methods: We included 351 subjects with varying clinical diagnoses from three cohorts with available FTP PET and CSF PTau181 within 18
‘Covert’ cerebral small vessel disease (ccSVD) is common on neuroimaging in persons without overt neurological manifestations, and increases the risk of future stroke, cognitive impairment, dependency, and death. These European Stroke Organisation (ESO) guidelines provide evidence-based recommendations to assist with clinical decisions about management of ccSVD, specifically white matter hyperinte
Quantitative data are needed to constrain the feedback loops between vegetation and hydroclimate. In this study, the amplitudes of variations in the triple oxygen isotope composition of water at the soil-plant-atmosphere interface are measured in savanna and dry forest contexts in West Africa (Benin and Senegal). Comparison of in situ data and model estimates reveals the following: (a) The value o
Background Postoperative pancreatic fistula (POPF) is a major complication after left pancreatectomy. The current International Study Group of Pancreatic Surgery classification has limitations, including heterogeneity in morbidity and high interobserver variability. This study aimed to assess POPF-related morbidity after left pancreatectomy and propose a refined classification system. Methods Pati
Background: Neoadjuvant therapy is protective of postoperative pancreatic fistula in pancreatoduodenectomy. However, the effect of neoadjuvant therapy after left pancreatectomy remains unclear. The aim of this international multicenter study was to evaluate the impact of neoadjuvant therapy on short term outcomes after left pancreatectomy for pancreatic ductal adenocarcinoma. Methods: Patients und
Following regulatory approval of anti-amyloid beta (Aβ) therapies, a better characterization of patients receiving these treatments is needed to guide clinical management and inclusion in future trials. This Alzheimer's Association-convened workgroup proposes a terminology, treatment-related amyloid clearance (TRAC), to reflect alterations in disease pathophysiology based on biomarker evidence for
FÖRHANDLINGSPROTOKOLL ORIGINAL Ärende Löner och allmänna anställningsvillkor Riksavtalet mellan Svensk Scenkonst och Akademikerförbunden avseende anställda vid offentligt finansierade teaterinstitutioner Parter Svensk Scenkonst Akademikerförbunden Datum Den 10/2, 16/2, 8/3, 29-30/3, 3/4, 17-19/4 samt per mail och telefon. Plats Teams samt Svensk Scenkonsts lokaler i Stockholm Närvarande för Arbets
Hanterade av Lunds universitets gemensamma förvaltning Här listas universitetsgemensamma interna nätverk som finns vid Lunds universitet och som utgår från den gemensamma förvaltningen. Listan är uppdelad efter sektion. Syftet är att ge en samlad bild av vad som finns och underlätta för dig som vill nå ut eller få information. Sektionen EkonomiSektionen Forskning, samverkan och innovationSektionen
https://www.medarbetarwebben.lu.se/organisation-och-styrning/organisation/interna-natverk - 2026-08-05
Forskare Kontaktinformation E-post: thomas [dot] holst [at] mgeo [dot] lu [dot] seOrganisation Miljö- och geovetenskapliga institutionen (MGeo) Hämtställe: 16 WebbplatsThomas Holsts profil i Lunds universitets forskningsportalAndra roller Medlem i Strategiskt forskningsområde BECC: Biodiversity and Ecosystem services in a Changing Climate Forskare Centrum för hälsosamma inomhusmiljöer, CHIE Medlem
https://www.nateko.lu.se/sv/thomas-holst - 2026-08-05
Kursbudget Välj kurs VT23 ERROR:#N/A Kursansvarig: Datum: Kursbudget Tilldelning ERROR:#N/A Utgifter Personalkostnader, GU-kont 0 kr Doktorandkostnader 0 kr Personal kostnader, ej GU kont 0 kr Driftskostnader m m 0 kr SUMMA kurskostnader 0 kr RESULTAT ERROR:#N/A Studerandeantal : kostnad/student: ERROR:#DIV/0! Instruktioner: Välj kurs i kurslistan. Då kommer tilldelningen upp. Fyll i datum och nam
https://www.biologyeducation.lu.se/sites/biologyeducation.lu.se/files/2022-12/KursbudgetmallVT23.xlsx - 2026-08-06
Kursbudget Välj kurs VT23 ERROR:#N/A Kursansvarig: Datum: Kursbudget Tilldelning ERROR:#N/A Utgifter Personalkostnader, GU-kont 0 kr Doktorandkostnader 0 kr Personal kostnader, ej GU kont 0 kr Driftskostnader m m 0 kr SUMMA kurskostnader 0 kr RESULTAT ERROR:#N/A Studerandeantal : kostnad/student: ERROR:#DIV/0! Instruktioner: Välj kurs i kurslistan. Då kommer tilldelningen upp. Fyll i datum och nam
https://www.biologyeducation.lu.se/sites/biologyeducation.lu.se/files/2023-06/KursbudgetmallVT23.xlsx - 2026-08-06
Kursbudget Välj kurs VT24 ERROR:#N/A Kursansvarig: Datum: Kursbudget Tilldelning ERROR:#N/A Utgifter Personalkostnader, GU-kont 0 kr Doktorandkostnader 0 kr Personal kostnader, ej GU kont 0 kr Driftskostnader m m 0 kr SUMMA kurskostnader 0 kr RESULTAT ERROR:#N/A Studerandeantal : kostnad/student: ERROR:#DIV/0! Instruktioner: Välj kurs i kurslistan. Då kommer tilldelningen upp. Fyll i datum och nam
https://www.biologyeducation.lu.se/sites/biologyeducation.lu.se/files/2024-04/KursbudgetmallVT24.xlsx - 2026-08-06
Kursbudget Välj kurs HT24 ERROR:#N/A Kursansvarig: Datum: Kursbudget Tilldelning ERROR:#N/A Utgifter Personalkostnader, GU-kont 0 kr Doktorandkostnader 0 kr Personal kostnader, ej GU kont 0 kr Driftskostnader m m 0 kr SUMMA kurskostnader 0 kr RESULTAT ERROR:#N/A Studerandeantal : kostnad/student: ERROR:#DIV/0! Instruktioner: Välj kurs i kurslistan. Då kommer tilldelningen upp. Fyll i datum och nam
https://www.biologyeducation.lu.se/sites/biologyeducation.lu.se/files/2024-08/KursbudgetmallHT24.xlsx - 2026-08-06
Allm studieplan hälsovet 2017 Postadress Box 117, 221 00 LUND Telefon växel 046-222 00 00 Telefax 046-222 41 70 E-post info@med.lu.se Internet http://www.med.lu.se Medic inska faku l te tss tyre lsen Allmän studieplan för utbildning på forskarnivå inom det hälsovetenskapliga området - arbetsterapi, omvårdnad, fysioterapi http://www.med.lu.se/utbildning/forskarutbildning (Fastställd av Medicinska f
https://www.intramed.lu.se/sites/intramed.lu.se/files/2022-12/allman-studieplan-halsovetenskaper-2017-01-01.pdf - 2026-08-06
